3 Alzheimer Headlines -- Promising Drug - Men - Statins

Updated July 26, 2021

Links in the original post broke.

You might also be interested in:

Treatments and Research - Alzheimer's Association

---  the original post follows below  ---

Alzheimer's is in the news. Follow this triple play of news. Methylene blue (Rember) shows promise, "New Alzheimer's drug shows early promise." "A milder type of mental decline that often precedes Alzheimer’s disease is alarmingly more common than has been believed, and in men more than women," as reported in this article," ‘Pre-Alzheimer’s’ rising, especially in men - Report: A million older Americans slide into mild mental decline each year." "Statin users were about half as likely to develop dementia, or to have cognitive impairment without dementia, as those who did not use statins," reports, "Statins Linked To Lower Dementia Risk. " 

Return Home: http://drughealth.blogspot.com/